Western blot analysis of pancreatic cancer cell lines proved that the combination treatment affected the levels of BCL2, known to be associated with apoptosis and cancer metastasis, and in tissues from treated mice, a decrease in BCL2 and phospho-STAT3 (Y705) was found. Here, BCL2 is linked to familial pancreatic carcinoma.